EN
DE
Home>Research

Publications

Select the publication year
Select an author  
  • Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing.
    Ahmad M, Krüger BT, Kroll T, Vettorazzi S, Dorn AK, Mengele F, Lee S, Nandi S, Yilmaz D, Stolz M, Tangudu NK, Vázquez DC, Pachmayr J, Cirstea IC, Spasic MV, Ploubidou A, Ignatius A, Tuckermann J
    Bone Res 2022, 10(1), 33
  • Quantification of noradrenergic-, dopaminergic-, and tectal-neurons during aging in the short-lived killifish Nothobranchius furzeri.
    Bagnoli S, Fronte B, Bibbiani C, Terzibasi Tozzini E, Cellerino A
    Aging Cell 2022, 21(9), e13689
  • ProteasomeID: quantitative mapping of proteasome interactomes and substrates for in vitro and in vivo studies
    Bartolome A, Heiby* JC, Dau* T, Di Fraia D, Heinze I, Kirkpatrick JM, Ori A
    bioRxiv 2022, https://doi.org/10.1101/2022.08. * equal contribution
  • The role of exosomes in inter-cellular and inter-organ communication of the peripheral nervous system.
    Bischoff JP, Schulz A, Morrison H
    FEBS Lett 2022, 596(5), 655-64
  • Impaired formation of neutrophil extracellular traps (NETs) in patients with myelodysplastic syndrome.
    Brings C, Fröbel J, Cadeddu RP, Germing U, Haas R, Gattermann N
    BLOOD ADV 2022, 6(1), 129-37
  • Disruption of amphetamine sensitization by alteration of dendritic thin spines in the nucleus accumbens core.
    Cai WT, Kim WY, Kwak MJ, Rim H, Lee SE, Riecken LB, Morrison H, Kim JH
    J Neurochem 2022, 161(3), 266-80
  • Upf3a is dispensable for nonsense-mediated mRNA decay in mouse pluripotent and somatic cells
    Chen C, Shen Y, Li L, Wang ZQ, Li T
    bioRxiv 2022, https://doi.org/10.1101/2022.07.
  • p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance.
    Coronel* L, Häckes* D, Schwab* K, Riege K, Hoffmann** S, Fischer** M
    Oncogene 2022, 41(7), 1063-9 * equal contribution, ** co-corresponding authors
  • Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells.
    Demircan MB, Mgbecheta PC, Kresinsky A, Schnoeder TM, Schröder K, Heidel FH, Böhmer FD
    Antioxidants (Basel) 2022, 11(3)
  • Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).
    Demircan MB, Schnoeder TM, Mgbecheta PC, Schröder K, Böhmer FD, Heidel FH
    J Cancer Res Clin Oncol 2022, 148(8), 1983-90